Dr. Christopher John Keats , MD
Psychoanalyst • Bellevue, WA
1300 114th Ave Se, Ste 210
Bellevue, WA 980046942
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Christopher Keats is listed in NPPES under Psychoanalyst.
-
NPI assigned on August 22, 2005; this date does not establish years in practice.
-
Published CMS data list 13 Medicare Part D prescriptions, including refills, in 2022.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2022. Published rows only; this is not a quality measure.
-
Published Part D records, 2022:
- Clonazepam — 13 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2022. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table · Guide: How to read Medicare Part D prescriber data
-
Medicare Part D prescriptions went from 23 in 2017 to 13 in 2022.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2017–2022.
Practice Location & Contact Primary Location
1300 114th Ave Se
Ste 210
Bellevue, WA 980046942
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Psychoanalyst: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
13 standardized 30-day fills in 2022
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$85 in 2022
The total cost of these prescriptions in 2022, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2022.
Industry payments (Open Payments)
Fewer than 11 payment records totaling $14.98 in 2025
Drug and medical device companies must report certain payments to doctors and some other clinicians to CMS, such as meals, travel, speaking fees or research funding.
It shows reported financial ties between this clinician and companies. You can ask your clinician about them.
These records are submitted by drug and medical device companies, and a reported payment does not necessarily mean the financial relationship is improper.
General: payments not tied to research, such as meals, travel, consulting or speaking fees.
A reported payment does not necessarily mean the financial relationship is improper. Research payments can go to a hospital or university for a study the clinician leads, not to the clinician personally. Clinicians can dispute records with the company that reported them.
Source: CMS Open Payments, program year 2025.
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Bellevue and Washington
4 active clinicians are listed under Psychoanalyst with a practice address in Bellevue, WA (16 in Washington).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 43% from 23 in 2017 to 13 in 2022.
- 2017: 23
- 2018: 36
- 2020: 14
- 2021: 12
- 2022: 13
-
30-day fills
30-day fills decreased 43% from 23 in 2017 to 13 in 2022.
- 2017: 23
- 2018: 39
- 2020: 14
- 2021: 12
- 2022: 13
-
Part D drug cost
Part D drug cost went from $285 in 2017 to $85 in 2022.
- 2017: $285
- 2018: $1,306
- 2020: $27
- 2021: $85
- 2022: $85
-
Industry payments (Open Payments)
CMS data for industry payments (Open Payments) are available for 2025 only.
Sources: CMS Medicare Part D Prescribers (2022), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): fewer than 11 records totaling $14.98.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Bausch & Lomb Americas Inc. |
Food and Beverage
In-kind items and services
|
— | General | $14.98 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2022.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Clonazepam | Clonazepam | 13 | 390 | $84.59 | — |
Source: CMS Part D by Provider and Drug, 2022; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 102L00000X
Psychoanalysis is a comprehensive, theoretical framework which, when applied to a treatment process, consists of an intensive verbal, therapeutic relationship between an analyst and an analysand which aims for symptom relief, emotional growth, and personal integration. The psychoanalytic treatment process includes, but is not limited to, the recognition of unconscious processes and conflicts; the significance of developmental influences; and the impact of resistances, defenses, transference and countertransference phenomena. Treatment is enhanced by an understanding developed in the analyst's training and personal analysis of unconscious manifestations, such as dreams, slips of the tongue, fantasies and day dreams. Psychoanalytic technique varies in relation to theoretical orientation.
Additional State Medicaid & Healthcare Payer Identifiers
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Psychiatry & Neurology - Psychiatry
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated August 22, 2005.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Mailing Address
1300 114th Ave Se, Ste 210
Bellevue, WA 980046942
Phone: 4254514761